Document:

EXHIBIT 4.9

 

NEITHER THIS WARRANT NOR THE SHARES
OF COMMON STOCK ISSUED UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE
STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED
IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE
STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL, IN A FORM ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID
ACT OR APPLICABLE STATE SECURITIES LAWS OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT.

 

SIMPLEPONS, INC.

 

PLACEMENT AGENT WARRANT TO PURCHASE

 

58,000 SHARES

 

OF COMMON STOCK

 

	Agent Warrant No.: PAW-____		Dated: __, 2012

 

SIMPLEPONS, INC.,
a Delaware corporation (the “Company”), hereby certifies that, for value received, Felix Investments
LLC or its Permitted Transferees (as hereinafter defined) (the “Holder”), is entitled to purchase from
the Company up to a total of ______________ (_____) shares of common stock, $0.01 par value per share (the “Common
Stock”), of the Company (each such share, a “Warrant Share” and all such shares, the “Warrant
Shares”) at an exercise price of $.25 (as adjusted from time to time as provided in Section 9, the “Exercise
Price”), at any time and from the date hereof and through _____, 2017 (the “Expiration Date”),
and subject to the following terms and conditions. The term “Common Stock,” as used herein shall include,
unless the context otherwise requires, the stock and other securities and property at the time receivable upon the exercise of
this Warrant. The term “Warrants,” as used herein, shall mean this Warrant and any other Warrants delivered
in substitution or exchange therefor as provided herein.

 

This Warrant (“Warrant”)
is issued pursuant to that certain Placement Agency Agreement (the “Placement Agency Agreement”), dated
February 15, 2012, by and between the Company and Felix Investments LLC (“Felix” or the “Placement
Agent”) as partial consideration for Felix accepting the appointment by the Company as the Company’s exclusive
placement agent in connection with the Company’s private placement (the “Offering”) of its shares
of Common Stock, pursuant to the Company’s Confidential Private Offering Memorandum dated February
15, 2012, as supplemented and amended from time to time (the “Memorandum”).

 

    	 

    	 

    
 

1.    Definitions.
In addition to the terms defined elsewhere in this Warrant, capitalized terms that are not otherwise defined herein have the meanings
given to such terms in the Placement Agency Agreement.

 

2.Registration
of Warrant. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant
Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered
Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and
for all other purposes, absent actual notice to the contrary.

 

3.Registration
of Transfers. The Company shall register the transfer and/or assignment of any portion of this Warrant to one or more Persons
(each a “Permitted Transferee”) in the Warrant Register, upon surrender of this Warrant, with the Form
of Assignment attached hereto duly completed and signed, to the Company’s transfer agent or to the Company at its address
specified herein. Upon any such registration or transfer, a new warrant to purchase Common Stock, in substantially the form of
this Warrant (any such new warrant, a “New Warrant”), evidencing the portion of this Warrant so transferred
shall be issued to the Permitted Transferee and a New Warrant evidencing the remaining portion of this Warrant not so transferred,
if any, shall be issued to the transferring Holder. The acceptance of the New Warrant by the Permitted Transferee thereof shall
be deemed the acceptance by such Permitted Transferee of all of the rights and obligations of a holder of a Warrant. For the purposes
hereof, the term “Person” means an individual, entity, corporation, partnership, association, limited
liability company, limited liability partnership, joint-stock company, trust or unincorporated organization.

 

4.Exercise
and Duration of Warrants.

 

(a)This Warrant
shall be exercisable by the registered Holder at any time and from time to time on or after the date hereof to and including the
Expiration Date. At 5:00 P.M., New York City time on the Expiration Date, the portion of this Warrant not exercised prior thereto
shall be and become void and of no value and this Warrant shall be terminated and no longer be outstanding.

 

(b)The Holder
may exercise this Warrant by delivering to the Company (i) an exercise notice, in the form attached hereto (the “Exercise
Notice”), appropriately completed and duly signed, and (ii) payment of the Exercise Price for the number of Warrant
Shares as to which this Warrant is being exercised (which may take the form of a “cashless exercise” if so indicated
in the Exercise Notice pursuant to Section 10

below), and the date such items are delivered to the Company (as determined in accordance with the notice
provisions hereof) is an “Exercise Date.” 

 

(c)Exercise
Disputes. In the case of any dispute with respect to the number of Warrant Shares to be issued upon exercise of this Warrant,
the Company shall promptly issue such number of Warrant Shares of Common Stock that is not disputed and shall submit the disputed
determinations or arithmetic calculations to the Holder via fax (or, it the Holder has not provided the Company with a fax number,
by overnight courier) within five (5) Business Days of receipt of the Holder’s election to purchase Warrant Shares. If the
Holder and the Company are

 

    	2

    	 

    
 

unable to agree as to the determination of the Exercise Price within five (5) Business Days of such
disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall in accordance with this
Section, submit via facsimile the disputed determination to its independent auditor. The Company shall cause its independent auditor
to perform the determinations or calculations and notify the Company and the Holder of the results promptly, in writing and in
sufficient detail to give the Holder and the Company a clear understanding of the issue. The determination by the Company’s
independent auditor shall be binding upon all parties absent manifest error. The Company shall then on the next Business Day instruct
its transfer agent to issue certificate(s) representing the appropriate number of Warrant Shares of Common Stock in accordance
with the independent auditor’s determination and this Section. The prevailing party shall be entitled to reimbursement of
all fees and expenses of such determination and calculation. For the purposes hereof, the term “Business Day”
means any day on which banks located in New York City are not required or authorized by law to remain closed.

 

5.Delivery
of Warrant Shares.

 

(a)Upon exercise
of this Warrant, the Company shall promptly (but in no event later than five (5) Business Days after the Exercise Date) issue or
cause to be issued and cause to be delivered to or upon the written order of the Holder and in such name or names as the Holder
may designate, a certificate for the Warrant Shares to which the Holder is entitled upon such exercise, free of restrictive legends
unless a registration statement covering the resale of the Warrant Shares and naming the Holder as a selling stockholder thereunder
is not then effective and the Warrant Shares are not freely transferable pursuant to Rule 144 under the Securities Act of 1933,
as amended (the “Securities Act”). To the extent the Warrant Shares may be issued free of restrictive
legends as set forth above, upon request of the Holder, the Company shall use its best efforts to deliver Warrant Shares hereunder
electronically through the Depository Trust Corporation or another established clearing corporation performing similar functions.

 

(b)This Warrant
is exercisable, either in its entirety or, from time to time, for a portion of the number of Warrant Shares. Upon surrender of
this Warrant following one or more partial exercises, the Company shall issue or cause to be issued, at its expense, a New Warrant
evidencing the right to purchase the remaining number of Warrant Shares.

 

(c)The Company’s
obligations to issue and deliver Warrant Shares in accordance with the terms hereof are absolute and unconditional, irrespective
of any action or inaction by the Holder to enforce the same, the recovery of any judgment against any Person or any action to enforce
the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder or
any other Person of any obligation to the Company or any violation or alleged violation of law by the Holder or any other Person,
and irrespective of any other circumstance which might otherwise limit such obligation of the Company to the Holder in connection
with the issuance of Warrant Shares. Nothing herein shall limit a Holder’s right to pursue any other remedies available to
it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with
respect to the Company’s failure to timely deliver certificates representing shares of Common Stock upon exercise of the
Warrant as required pursuant to the terms hereof.

 

    	3

    	 

    
 

6.Charges,
Taxes and Expenses. Issuance and delivery of certificates for Warrant Shares upon exercise of this Warrant shall be made without
charge to the Holder for any issue or transfer tax, withholding tax, transfer agent fee or other incidental tax or expense in respect
of the issuance of such certificates, all of which taxes and expenses shall be paid by the Company; provided, however,
that the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the registration
of any certificates for Warrant Shares or Warrants in a name other than that of the Holder. The Holder shall be responsible for
all other tax liability that may arise as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise
hereof.

 

7.Replacement
of Warrant. If this Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange
and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon
receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction and customary and reasonable bond
or indemnity, if requested. Applicants for a New Warrant under such circumstances shall also comply with such other reasonable
regulations and procedures and pay such other reasonable third-party costs as the Company may prescribe.

 

8.Reservation
of Warrant Shares. The Company covenants that it will at all times reserve and keep available out of the aggregate of its
authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue Warrant Shares upon
exercise of this Warrant as herein provided, the number of Warrant Shares which are then issuable and deliverable upon the exercise
of this entire Warrant, free from preemptive rights or any other contingent purchase rights of persons other than the Holder (after
giving effect to the adjustments and restrictions of Section 9, if any). The Company covenants that all Warrant Shares
so issuable and deliverable shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms
hereof, be duly and validly authorized, issued and fully paid and nonassessable. The Company will take all such action as may
be necessary to assure that such shares of Common Stock may be issued as provided herein without violation of any applicable law
or regulation, or of any requirements of any securities exchange or automated quotation system upon which the Common Stock may
be listed.

 

9.Certain
Adjustments. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment
from time to time as set forth in this Section 9.

 

(a)Stock
Dividends and Splits. If the Company, at any time while this Warrant is outstanding, (i) pays a stock dividend on its Common
Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock, (ii) subdivides
outstanding shares of Common Stock into a larger number of shares, or (iii) combines outstanding shares of Common Stock into a
smaller number of shares, then in each such case the Exercise Price shall be multiplied by a fraction of which the numerator shall
be the number of shares of Common Stock outstanding immediately before such event and of which the denominator shall be the number
of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to clause (i) of this paragraph
shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend
or distribution, and any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become effective immediately after
the effective date of such subdivision or combination.

 

    	4

    	 

    
 

(b)Fundamental
Transactions. If at any time prior to the Expiration Date of this Warrant the Company proposes to engage in a “Fundamental
Transaction” (as hereinafter defined) then, and in any one or more of such cases, the Company will give to the Holder(s)
at least ten (10) days’ prior written notice of the date on which the books of the Company will close or a record will be
taken for determining rights to vote with respect to such Fundamental Transaction. Such notice will describe the nature of the
Fundamental Transaction, the date on which the holders of their Common Stock will be entitled thereto, and such notice will also
specify the date on which the holders of the Common Stock will be entitled to exchange the Common Stock for securities or other
property deliverable upon the consummation of the Fundamental Transaction. A “Fundamental Transaction”
is any (i) merger or consolidation of the Company with or into (unless the Company is the surviving corporation) another Person,
(ii) any sale, assignment, transfer, conveyance or other disposition by the Company of all or substantially all of its assets
in one or a series of related transactions; provided, however, that for avoidance of doubt, the granting of a lien
on all or substantially all of the Company’s assets as collateral shall not be deemed a Fundamental Transaction hereunder,
(iii) purchase, tender or exchange offer by the Company (or to which the Company is a party) that will be for more than 50% of
the outstanding shares of Common Stock (not including any shares of Common Stock held by the Person or Persons making or party
to, or associated or affiliated with the Persons making or party to, such purchase, tender or exchange offer), (iv) business combination
(including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) requiring shareholder approval
with another Person whereby such other Person acquires more than the 50% of the outstanding shares of Common Stock (not including
any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the
other Persons making or party to, such stock purchase agreement or other business combination), or (v) reclassification of the
Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property (other than as a result of a subdivision or combination of shares of Common Stock covered by
Section 9 (a) above).

 

(c)Adjustments
for Other Dividends and Distributions. In the event the Company at any time or from time to time while this Warrant is outstanding
makes, or fixes a record date for the determination of holders of Common Stock entitled to receive a dividend or other distribution
payable in securities of the Company other than shares of Common Stock, then and in each such event provision shall be made so
that the Holder of this Warrant shall receive upon exercise hereof, in addition to the number of shares of Common Stock receivable
hereupon, the amount of securities of the Company which the Holder would have received had this Warrant been exercised on the date
of such event and had Holder thereafter, during the period from the date of such event to and including the exercise date, retained
such securities receivable by the Holder as aforesaid during such period, subject to all other adjustments called for during such
period under this Section 9 with respect to the rights of the Holder of this Warrant.

 

(d)The Company
will not by reorganization, transfer of assets, consolidation, merger, dissolution, or otherwise, avoid or seek to avoid observance
or performance of any of the terms of this Section 9, but will at all times in good faith assist in the carrying out and
performance of all provisions of this Section 9 in order to protect the rights of the Holder against impairment.

 

    	5

    	 

    
 

(e)Number
of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to paragraph (a) of this Section, the
number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately,
as applicable, so that after such adjustment the aggregate Exercise Price payable hereunder for the increased or decreased, as
applicable, number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment.

 

(f)Calculations.
All calculations under this Section 9 shall be made to the nearest cent or the nearest share, as applicable. The
number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for the account
of the Company, and the disposition of any such shares shall be considered an issue or sale of Common Stock.

 

(g)Notice
of Adjustments. Upon the occurrence of each adjustment pursuant to this Section 9, the Company at its expense will
promptly compute such adjustment in accordance with the terms of this Warrant and prepare a certificate setting forth such adjustment,
including a statement of the adjusted Exercise Price and adjusted number or type of Warrant Shares or other securities issuable
upon exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments and showing in detail
the facts upon which such adjustment is based. Upon written request, the Company will promptly deliver a copy of each such certificate
to the Holder and to the Company’s Transfer Agent.

 

(h)Notice
of Corporate Events. If the Company (i) declares a dividend or any other distribution of cash, securities or other property
in respect of its Common Stock, including without limitation any granting of rights or warrants to subscribe for or purchase any
capital stock of the Company or any subsidiary, (ii) authorizes or approves, enters into any agreement contemplating or solicits
stockholder approval for any Fundamental Transaction or (iii) authorizes the voluntary dissolution, liquidation or winding up of
the affairs of the Company, then the Company shall deliver to the Holder a notice describing the material terms and conditions
of such transaction, at least ten calendar days prior to the applicable record or effective date on which a Person would need to
hold Common Stock in order to participate in or vote with respect to such transaction, and the Company will take all steps reasonably
necessary in order to insure that the Holder is given the practical opportunity to exercise this Warrant prior to such time so
as to participate in or vote with respect to such transaction; provided, however, that the failure to deliver such
notice or any defect therein shall not affect the validity of the corporate action required to be described in such notice.

 

10.Payment
of Exercise Price. The Holder shall pay the Exercise Price in immediately available funds (a “cash exercise”);
or the Holder may satisfy its obligation to pay the Exercise Price through a “cashless exercise,” in
which event the Company shall issue to the Holder the number of Warrant Shares determined as follows:

 

    	6

    	 

    
 

	 	X = Y [(A-B)/A]
	where:	 
	 	X = the number of Warrant Shares to be issued to the Holder.
	 	 
	 	Y = the number of Warrant Shares with respect to which this Warrant is being exercised (prior to cashless exercise).
	 	 
	 	A = the average of the Closing Prices for the five (5) Trading Days immediately prior to (but not including) the Exercise Date.
	 	 
	 	B = the Exercise Price.

 

For purposes of this Section 10, “Closing
Prices” for any date, shall mean the closing price per share of the Common Stock for such date (or the nearest preceding
date) on the primary trading market on which the Common Stock is then listed or quoted.

 

For purposes of Rule 144 promulgated under the Securities Act,
it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to
have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date
this Warrant was originally issued pursuant to the Placement Agency Agreement (provided the Securities and Exchange Commission
continues to take the position that such treatment is proper at the time of such exercise).

 

11.Limitation
on Exercise. Notwithstanding anything to the contrary contained herein, the number of shares of Common Stock that may be
acquired by the Holder upon any exercise of this Warrant (or otherwise in respect hereof) shall be limited to the extent
necessary to insure that, following such exercise (or other issuance), the total number of shares of Common Stock then
beneficially owned by such Holder and its affiliates and any other Persons whose beneficial ownership of Common Stock would
be aggregated with the Holder’s for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), does not exceed 4.9% (the “Maximum Percentage”) of the
total number of issued and outstanding shares of Common Stock (including for such purpose the shares of Common Stock issuable
upon such exercise). For such purposes, “beneficial ownership” shall be determined in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. The Company’s obligation
to issue shares of Common Stock in excess of the limitation referred to in this Section shall be suspended (and shall not
terminate or expire notwithstanding any contrary provisions hereof) until such time, if any, as such shares of Common Stock
may be issued in compliance with such limitation, but in no event later than the Expiration Date. By written notice to the
Company, the Holder may waive the provisions of this Section or increase or decrease the Maximum Percentage to any other
percentage specified in such notice, but (i) any such waiver or increase will not be effective until the 61st day after such
notice is delivered to the Company, and (ii) any such waiver or increase or decrease will apply only to the Holder and
not to any other holder of Warrants.

 

12.Fractional
Shares. The Company shall not be required to issue or cause to be issued fractional Warrant Shares on the exercise of this
Warrant. In lieu of any fractional shares which would, otherwise be issuable, subject to Section 11, the Company shall pay
the Holder entitled to such fractional Warrant Share a sum in cash equal to such fraction (calculated to the nearest 1/100th
of a Warrant Share) multiplied by the then effective Exercise Price.

 

    	7

    	 

    
 

13.Notices.
Any and all notices or other communications or deliveries hereunder (including without limitation any Exercise Notice) shall be
in writing and shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication
is delivered via facsimile at the facsimile number specified in the Placement Agency Agreement prior to 5:00 p.m. (New York City
time) on a Business Day, (ii) the next Business Day after the date of transmission, if such notice or communication is delivered
via facsimile at the facsimile number specified in the Purchase Agreement on a day that is not a Business Day or later than 5:00
p.m. (New York City time) on any Business Day, (iii) the Business Day following the date of mailing if sent by nationally recognized
overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. The address for
such notices or communications shall be as set forth in the Placement Agency Agreement.

 

14.Warrant
Agent. The Company shall serve as warrant agent under this Warrant. Upon thirty (30) days’ notice to the Holder, the
Company may appoint a new warrant agent. Any corporation and/or other entity into which the Company or any new warrant agent may
be merged or any corporation resulting from any consolidation to which the Company or any new warrant agent shall be a party shall
be a successor warrant agent under this Warrant without any further act. Any such successor warrant agent shall promptly cause
notice of its succession as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder’s
last address as shown on the Warrant Register.

 

15.Automatic
Conversion upon Expiration. Subject to Section 11, in the event that, upon the Expiration Date, the Closing Prices per
share of Common Stock (or other security issuable upon the exercise hereof) as determined in accordance with Section 10
above is greater than the Exercise Price in effect on such date, then this Warrant shall automatically be deemed on and as of such
date to be converted on a cashless basis pursuant to Section 11 above as to all Warrant Shares (or such other securities)
for which it shall not previously have been exercised. Upon surrender of this Warrant as provided in Section 11 above, the
Company shall promptly deliver a certificate representing the Warrant Shares (or such other securities) issued upon such conversion
to Holder.

 

16.Registration
Rights. The Holder of this Warrant is entitled to have the shares of Common Stock issuable upon exercise of this Warrant registered
for resale under the Securities Act, pursuant to and in accordance with the Registration Rights Agreement (as defined in the Memorandum)
by and between the Investors in the Offering and the Company which rights are expressly incorporated and made a part of this Warrant.

 

17.Loss
or Mutilation. Upon receipt by the Company of evidence satisfactory to it (in the exercise of reasonable discretion) of the
ownership of and the loss, theft, destruction or mutilation of any Warrant and (in the case of loss, theft or destruction) of indemnity
satisfactory to it (in the exercise of reasonable discretion), and (in the case of mutilation) upon surrender and cancellation
thereof, the Company will execute and deliver in lieu thereof a new Warrant of like tenor.

 

    	8

    	 

    
 

18.

 

19.Miscellaneous.

 

(a)Assignment;
Binding Agreement. Subject to the restrictions on transfer set forth on the first page hereof, this Warrant may be transferred
or assigned by the Holder to a Permitted Transferee pursuant to Section 3 provided, that, among other things, the Permitted
Transferee covenants to be bound by the terms hereof. This Warrant may not be assigned by the Company, except to a successor in
the event of a Fundamental Transaction. This Warrant shall be binding on and inure to the benefit of the parties hereto and their
respective successors and assigns. Subject to the preceding sentence, nothing in this Warrant shall be construed to give to any
Person other than the Company and the Holder any legal or equitable right, remedy or cause of action under this Warrant.

 

(b)No Interference.
The Company will not, by amendment of its governing documents or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action, seek to call or redeem this Warrant or avoid or
seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in
the carrying out of all such terms and in the taking of all such action as may be necessary or appropriate in order to protect
the rights of the Holder against dilution or other impairment. Without limiting the generality of the foregoing, the Company (i)
will not increase the par value of any Warrant Shares above the amount payable therefor on such exercise, (ii) will take all such
action as may be reasonably necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable
Warrant Shares, free from all taxes, liens, security interests, encumbrances, preemptive or similar rights and charges of stockholders
(other than those imposed by the Holders), on the exercise of the Warrant, and (iii) will not close its stockholder books or records
in any manner which interferes with the timely exercise of this Warrant.

 

(c)Remedies;
Specific Performance. The Company acknowledges and agrees that there would be no adequate remedy at law to the Holder of this
Warrant in the event of any default or threatened default by the Company in the performance of or compliance with any of the terms
of this Warrant and accordingly, the Company agrees that, in addition to any other remedy to which the Holder may be entitled at
law or in equity, the Holder shall be entitled to seek to compel specific performance of the obligations of the Company under this
Warrant, without the posting of any bond, in accordance with the terms and conditions of this Warrant in any court of the United
States or any State thereof having jurisdiction, and if any action should be brought in equity to enforce any of the provisions
of this Warrant, the Company shall not raise the defense that there is an adequate remedy at law. Except as otherwise provided
by law, a delay or omission by the Holder hereof in exercising any right or remedy accruing upon any such breach shall not impair
the right or remedy or constitute a waiver of or acquiescence in any such breach. No remedy shall be exclusive of any other remedy.
All available remedies shall be cumulative.

 

(d)Amendments
and Waivers. No terms of this Warrant may be amended, waived or modified except by the express written consent of the Company
and the Holder.

 

    	9

    	 

    
 

(e)Governing
Law; Venue; Waiver Of Jury Trial, Etc. This Warrant shall be governed by and construed solely and exclusively under and pursuant
to the laws of the State of New York as applied to agreements among New York residents entered into and to be performed
entirely within New York. Each of the parties hereto expressly and irrevocably (1) agree that any legal suit, action or proceeding
arising out of or relating to this Warrant will be instituted exclusively in either the New York State Supreme Court, County
of New York, or in the United States District Court for the Southern District of New York, (2) waive any objection
they may have now or hereafter to the venue of any such suit, action or proceeding, and (3) consent to the in personam
jurisdiction of either the New York State Supreme Court, County of New York, or the United States District Court for
the Southern District of New York in any such suit, action or proceeding. Each of the parties hereto further agree to accept
and acknowledge service of any and all process which may be served in any such suit, action or proceeding in either the New York
State Supreme Court, County of New York, or in the United States District Court for the Southern District of New York
and agree that service of process upon it mailed by certified mail to its address will be deemed in every respect effective service
of process upon it, in any such suit, action or proceeding. THE PARTIES HERETO AGREE TO WAIVE THEIR RESPECTIVE RIGHTS TO A JURY
TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS WARRANT OR ANY DOCUMENT OR AGREEMENT CONTEMPLATED HEREBY.
THE PARTY PREVAILING THEREIN SHALL BE ENTITLED TO PAYMENT FROM THE OTHER PARTY HERETO OF ALL OF ITS REASONABLE COUNSEL FEES AND
DISBURSEMENTS.

 

(f)Headings
The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect
any of the provisions hereof.

 

(g)Partial
Invalidity. In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the
validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired
thereby and the parties will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially
reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Warrant.

 

IN WITNESS
WHEREOF, the Company has caused this Warrant to be duly executed by its authorized officer as of the date first indicated above.

 

	 	SIMPLEPONS, INC.
	 	 	 
	 	 	 
	 	By:	 
	 	Name: Martin Scott
	 	Title: Chief Financial Officer

 

    	10

    	 

    

 

FORM OF EXERCISE NOTICE

 

(To be executed by the Holder to exercise
the right to purchase shares of Common Stock under the foregoing Warrant)

 

To: SIMPLEPONS, INC.

 

The undersigned is the Holder of Warrant
No. PAW-101 (the “Warrant”) issued by SimplePons, Inc., a Delaware corporation (the “Company”).
Capitalized terms used herein and not otherwise defined have the respective meanings set forth in the Warrant.

 

	(a)		The Warrant is currently exercisable to purchase a total of ______________ Warrant
Shares.
	 	 	 
	(b)		The undersigned Holder hereby exercises its right to purchase _________________ Warrant
Shares pursuant to the Warrant.
	 	 	 
	(c)		The Holder shall make Payment of the Exercise Price as follows (check one):
	 	 	 
	 	 	______ “Cash Exercise” under Section
10
	 	 	______ “Cashless Exercise” under Section 10

	 	 	 
	(d)		If the holder is making a Cash Exercise, the holder shall pay the sum of $____________
to the Company in accordance with the terms of the Warrant.
	 	 	 
	(e)		Pursuant to this exercise, the Company shall deliver to the holder ______________
Warrant Shares in accordance with the terms of the Warrant.
	 	 	 
	(f)		Following this exercise, the Warrant shall be exercisable to purchase a total of ______________
Warrant Shares.
	 	 	 
	(g)		Notwithstanding anything to the contrary contained herein, this Exercise Notice shall
constitute a representation by the Holder that, after giving effect to the exercise provided for in this Exercise Notice, the
Holder (together with its affiliates) will not have beneficial ownership (together with the beneficial ownership of such Person’s
affiliates) of a number of shares of Common Stock which exceeds the Maximum Percentage of the total outstanding shares of Common
Stock as determined pursuant to the provisions of Section 11 of the Warrant.

 

    	 

    	 

    
 

	(h)		The Holder represents that, as of the date of exercise:

 

	i.		the Warrant Shares being purchased pursuant to this Exercise Notice are being acquired
solely for the Holder’s own account and not as a nominee for any other party, for investment, and not with a view toward
distribution or resale; and
	 	 	 
	ii.		the Holder is an “accredited investor” as such term is defined
in Rule501(a)(1) of Regulation D promulgated by the Securities and Exchange Commission under the Securities Act.

 

	(i)		If the Holder cannot make the representations required in Section (h)(ii),
above, because it is factually incorrect, it shall be a condition to the exercise of the Warrant that the Company receive such
other representations as the Company considers necessary, acting reasonably, to assure the Company that the issuance of securities
upon exercise of this Warrant shall not violate any United States or other applicable securities laws.

 

	Dated: _________________, _________	 	Name of Holder:__________________________________
	 	 	                                                                (Print)
	 	 	 
	 	 	By:______________________________________
	 	 	Name:____________________________________
	 	 	Title:_____________________________________
	 	 	(Signature must conform in all respects to name of holder as specified on the face of the Warrant)

 

    	 

    	 

    
 

FORM OF ASSIGNMENT

 

[To be completed and signed only upon transfer
of Warrant]

 

FOR VALUE RECEIVED,
the undersigned hereby sells, assigns and transfers unto ________________________________ the right represented by the within Warrant
to purchase ____________ shares of Common Stock of SimplePons, Inc. to which the within Warrant relates and appoints ________________
attorney to transfer said right on the books of SimplePons, Inc. with full power of substitution in the premises.

 

The undersigned transferee
agrees to be bound by the covenants of the Warrant Holder during the term of the Warrant.

 

The undersigned transferee
agrees represents and warrants that:

 

	i.		the Warrant Shares being purchased pursuant to this Assignment are being acquired
solely for the transferee’s own account and not as a nominee for any other party, for investment, and not with a view toward
distribution or resale; and
	 	 	 
	ii.		the undersigned transferee is an “accredited investor” as such
term is defined in Rule501(a)(1) of Regulation D promulgated by the Securities and Exchange Commission under the Securities Act.

 

If the
undersigned transferee cannot make the representations required in clause (ii) above, above, because it is factually incorrect,
it shall be a condition to the transfer of the Warrant that the Company receive such other representations as the Company considers
necessary, acting reasonably, to assure the Company that the transfer this Warrant shall not violate any United States or other
applicable securities laws.

 

	Dated: ___________________, _________	 
	 	                                                                                                  
	 	(Signature must conform in all respects to name of holder as specified on the face of the Warrant)
	 	 
	 	                                                                                          
	 	Address of Transferee
	 	 
	 	                                                                                          
	 	 
	 	                                                                                          
	 	 
	 	 
	In the presence of:	                                                                                          
	 	Signature of TransfereeEXHIBIT 10.10

 

REGISTRATION RIGHTS AGREEMENT

 

This REGISTRATION
RIGHTS AGREEMENT (this “Agreement”) is made as of February 15, 2012, by and among (i) SimplePons,
Inc., a Delaware corporation (the “Company”), (ii) each person listed on Annex A attached
hereto, as may be amended from time to time (each a “Purchaser” and, collectively, the “Purchasers”),
and (iii) each person or entity that subsequently becomes a party to this Agreement pursuant to, and in accordance with, the provisions
of Section 10 hereof (each a “Purchaser Permitted Transferee” and, collectively, the “Purchaser
Permitted Transferees”).

 

WHEREAS, pursuant to
the terms and conditions set forth in Subscription Agreements (each, a “Subscription Agreement”), the
Company has agreed to issue and sell to the Purchasers, and the Purchasers have agreed to purchase from the Company, up to an aggregate
of twenty-four million (24,000,000) shares (each, a “Share” and collectively, the “Shares”)
of the Company’s common stock, par value $.01 per Share (the “Common Stock”) for an aggregate purchase
price of $6,000,000 (the “Offering”), subject to an oversubscription option to purchase up to an additional
eight million (8,000,000) Shares ($2,000,000); and

 

WHEREAS, as partial
consideration for each Purchaser’s purchase of Shares in the Offering, the Company has agreed to provide each Purchaser with
the registration rights set forth herein with respect to the resale of the Shares purchased by the Purchasers in the Offering;
and

 

NOW, THEREFORE, in
consideration of the promises and mutual covenants contained herein, the parties hereto hereby agree as follows:

 

1.   DEFINITIONS.
The following terms shall have the meanings provided therefor below:

 

“Business
Day” means a day, other than a Saturday or Sunday, on which banks in New York City are open for the general transaction
of business.

 

“Closing”
shall have the meaning ascribed to such term in the Memorandum.

 

“Effectiveness
Date” means the date a Registration Statement is declared effective by the SEC.

 

“Effectiveness
Deadline” means the date that is one hundred and fifty (150) calendar days after the date of the Final Closing.

 

“Exchange
Act” shall mean the Securities Exchange Act of 1934, as amended, and all of the rules and regulations promulgated
thereunder.

 

“Filing
Date” shall mean, with respect to the Initial Registration Statement, the date sixty (60) calendar days after the
Final Closing, provided, however, that if the Filing Date falls on a Saturday, Sunday or other day, that the SEC
is closed for business the Filing Date shall be extended to the next Business Day.

 

    	1

    	 

    

 

“Final
Closing” means the final Closing of the Offering pursuant to the Memorandum.

 

“Holder”
or “Holders” shall mean the holder or holders, as the case may be, from time to time, of Registrable
Securities.

 

“Initial
Registration Statement” shall mean the initial Registration Statement filed pursuant to this Agreement.

 

“Memorandum”
shall mean the Confidential Private Placement Memorandum dated February 15, 2012, as may be amended or supplemented from time to
time.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or agency or subdivision thereof) or other entity of any kind.

 

“Purchaser
Permitted Transferees” shall have the meaning ascribed to such term in the Preamble.

 

“Purchasers”
shall mean, collectively, the Purchasers and the Purchaser Permitted Transferees; provided, however, that the term
“Purchasers” shall not include any of the Purchasers or any of the Purchaser Permitted Transferees that do not own
or hold any Registrable Securities.

 

“Registrable
Securities” shall mean the Shares.

 

“Registration
Statement” means any one or more registration statements filed (and/or required to be filed pursuant hereto) with
the SEC by the Company on Form S-3, or in the event the Company is not eligible to use Form S-3, on Form S-1, for the purpose of
registering the Registrable Securities, including (in each case) the prospectus, amendments and supplements to such registration
statement or prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by reference
or deemed to be incorporated by reference in such registration statement. The term “Registration Statement” shall include,
but not be limited to, the Initial Registration Statement.

 

“Rule 144”
shall mean Rule 144 promulgated by the SEC pursuant to the Securities Act and any successor or substitute rule, law or provision.

 

“Rule 172”
means Rule 172 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar
rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such Rule.

 

    	2

    	 

    

 

“Rule 424”
means Rule 424 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar
rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such Rule.

 

“SEC”
shall mean the United States Securities and Exchange Commission.

 

“SEC Guidance”
means (i) any publicly-available written guidance, or rule of general applicability of the SEC staff, or (ii) oral or written comments,
requirements or requests of the SEC staff to the Company in connection with the review of a Registration Statement.

 

“Securities
Act” shall mean the Securities Act of 1933, as amended, and all of the rules and regulations promulgated thereunder.

 

“Trading
Day” shall mean any day on which the Common Stock is traded for any period on the OTCBB, or on the principal securities
exchange or other securities market on which the Common Stock is then being traded.

 

2.   MANDATORY REGISTRATION.

 

(a)   The Company shall
file an Initial Registration Statement on or prior to the Filing Date registering the Registrable Securities for resale by the
Holders as selling stockholders thereunder. On or prior to the Filing Date, the Company shall prepare and file with the SEC an
Initial Registration Statement for the purpose of registering under the Securities Act the resale of all, or such portion as permitted
by SEC Guidance (and the Company shall use its best efforts to advocate with the SEC for the registration of all or the maximum
number of the Registrable Securities as permitted by SEC Guidance) of the Registrable Securities by, and for the account of, the
Holders as selling stockholders thereunder, that are not then registered on an effective Registration Statement for an offering
to be made on a continuous basis pursuant to Rule 415. The Company shall use its best efforts to cause the Initial Registration
Statement to be declared effective by the SEC under the Securities Act as promptly as practicable after the filing thereof, but
in any event on or prior to the applicable Effectiveness Deadline.

 

(b)   The Company shall
be required to keep the Initial Registration Statement current and effective until such date that is the earlier of (the “Effectiveness
Period”) (i) the date as of which all of the Holders as selling stockholders thereunder may sell all of the Registrable
Securities registered for resale thereon without restriction pursuant to Rule 144, or (ii) the date when all of the Registrable
Securities registered thereunder shall have been sold (such date is referred to herein as the “Mandatory Registration
Termination Date”), or (iii) three (3) years from the effective date of the Initial Registration Statement. Thereafter,
the Company shall be entitled to withdraw such Registration Statement and the Holders shall have no further right to offer or sell
any of the Registrable Securities registered for resale thereon pursuant to the respective Registration Statement (or any prospectus
relating thereto).

 

    	3

    	 

    
 

(c)   Notwithstanding any
other provision of this Agreement, if any SEC Guidance sets forth a limitation on the number of Registrable Securities to be registered
in the Initial Registration Statement (and the Company has used its best efforts to advocate with the SEC for the registration
of all or the maximum number of Registrable Securities), the number of Registrable Securities to be registered on such Registration
Statement will be reduced on a pro rata basis among the Purchasers based on the total number of unregistered Shares held by such
Purchasers on a fully diluted basis. The Company shall file a new registration statement as soon as reasonably practicable covering
the resale by the Holders of not less than the number of such Registrable Securities that are not registered in the Initial Registration
Statement. The Company shall not be liable for liquidated damages under Section 3(a) as to any Registrable Securities which
are not permitted by the SEC to be included in a Registration Statement due solely to SEC Guidance from time to time. In such case,
any liquidated damages payable under Section 3(a) shall be calculated to apply only to the percentage of Registrable Securities
which are permitted in accordance with SEC Guidance to be included in such Registration Statement.

 

(d)   If during the Effectiveness
Period, the Company becomes aware that the number of Registrable Securities at any time exceeds the number of Registrable Securities
then registered for resale in a Registration Statement, then the Company shall file as soon as reasonably practicable an additional
Registration Statement covering the resale by the Holders of not less than the number of such Registrable Securities that are not
then registered.

 

3.   PENALTIES/SUSPENSION
OF A REGISTRATION STATEMENT.

 

(a)   If: (i) the Initial
Registration Statement and any other Registration Statement is not filed on or prior to the Filing Date, or (ii) the Company fails
to file with the SEC a request for acceleration in accordance with Rule 461 promulgated under the Securities Act, within five (5)
Business Days of the date that the Company is notified (orally or in writing, whichever is earlier) by the SEC that the Initial
Registration Statement or any other Registration Statement will not be “reviewed” or not be subject to further review,
or (iii) prior to the Effectiveness Deadline of the Initial Registration Statement or any other Registration Statement, the Company
fails to file a pre-effective amendment and otherwise respond in writing to comments made by the SEC in respect of such Initial
Registration Statement or any other Registration Statement within ten (10) Business Days after the receipt of comments by or notice
from the SEC that such amendment is required in order for such Initial Registration Statement or any other Registration Statement
to be declared effective, or (iv) the Initial Registration Statement and/or any other Registration Statement covering Registrable
Securities is not declared effective by the SEC by the Effectiveness Deadline, or (v) after the Effectiveness Date of the Initial
Registration Statement or any other Registration Statement, other than during an Allowable Grace Period (as defined below) such
Initial Registration Statement or other Registration Statement ceases for any reason to remain for any period current and effective
as to all Registrable Securities included in such Initial Registration Statement or other Registration Statement, as applicable,
or the Purchasers are otherwise not permitted to utilize the prospectus therein to resell such Registrable Securities (any such
failure or breach being referred to as an “Event,” and the date such default occurs referred to as an
“Event Date”), then, in addition to any other rights the Purchasers may have hereunder or under applicable
law, on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not have been
cured by such date) until the applicable Event is cured, the Company shall, subject to Section 3(c), pay to each Purchaser
on a monthly basis within three (3) Business Days of the end of the month either an amount in cash, as partial liquidated damages,
equal to one percent (1%) of the aggregate purchase price paid by each Purchaser to purchase any Registrable Securities then held
by such Purchaser (the “Penalty”), provided, however, that the Company, within its sole
discretion, shall have the right to elect to pay the Penalty in shares of its common stock with each Share valued at a price equal
to fair market value of the Share on the date of issuance. The partial liquidated damages pursuant to the terms hereof shall
apply on a daily pro-rata basis for any portion of a month prior to the cure of an Event.

 

    	4

    	 

    
 

(b)    The Company
shall notify each Holder and the Placement Agent by facsimile or e-mail as promptly as practicable, and in any event, within three
(3) Business Days, after a Registration Statement is declared effective and shall simultaneously provide the Purchasers with a
copy of any related prospectus to be used in connection with the sale or other disposition of the Registrable Securities covered
thereby. Failure to notify the Holders in accordance with this Section 3(b) shall be deemed an Event under Section 3(a).

 

(c)   No Purchaser shall
be entitled to a payment pursuant to this Section 3 if effectiveness of a Registration Statement has been delayed or
a prospectus has been unavailable as a result of (i) a failure by such Purchaser to promptly provide on request by the Company
the information required under the Subscription Agreement or this Agreement or requested by the SEC as a condition to effectiveness
of a Registration Statement; (ii) the provision of inaccurate or incomplete information by such Purchaser; or (iii) a statement
or determination of the SEC that any provision of the rights of the Purchaser under this Agreement are contrary to the provisions
of the Securities Act.

 

(d)   Notwithstanding
anything to the contrary herein, at any time after the Effectiveness Date of a particular Registration Statement, the Company may
delay the disclosure of material, non-public information concerning the Company or SimplePons Operations, Inc., its wholly-owned
subsidiary (the “Subsidiary”), the disclosure of which at the time is not, in the good faith opinion
of the board of directors of the Company, in the best interest of the Company and, in the opinion of counsel to the Company, otherwise
required (a “Grace Period”), provided that the Company shall promptly notify the Purchasers in writing
of the (i) existence of material, non-public information giving rise to a Grace Period (provided that in each such notice the Company
shall not disclose the content of such material, non-public information to any of the Purchasers) and the date on which such Grace
Period will begin and (ii) date on which such Grace Period ends, provided further that (i) no Grace Period shall exceed ten (10)
consecutive days and during any three hundred sixty five (365) day period all such Grace Periods shall not exceed an aggregate
of thirty (30) days, (ii) the first day of any Grace Period must be at least five (5) Trading Days after the last day of any prior
Grace Period, and (iii) no Grace Period may exist during the thirty (30) Trading Day period immediately following the Effectiveness
Date of such Registration Statement (provided that such thirty (30) Trading Day period shall be extended by the number of Trading
Days during such period and any extension thereof contemplated by this proviso during which such Registration Statement is not
effective or the prospectus contained therein is not available for use) (each, an “Allowable Grace Period”).
For purposes of determining the length of a Grace Period above, such Grace Period shall begin on and include the date the Purchasers
receive the notice referred to in clause (i) above and shall end on and include the later of the date the Purchasers receive the
notice referred to in clause (ii) above and the date referred to in such notice. 

 

    	5

    	 

    

 

4.   OBLIGATIONS OF
THE COMPANY. With respect to the Initial Registration Statement and any other Registration Statement filed by the Company with
the SEC that covers the Registrable Securities, the Company shall:

 

(a)   Prepare and file
with the SEC such amendments and supplements to a Registration Statement and the prospectus used in connection therewith as may
be necessary to comply with the provisions of the Securities Act with respect to the disposition of all Registrable Securities
covered by a Registration Statement;

 

(b)   Furnish to the selling
Holders such number of copies of a prospectus, including a preliminary prospectus, in conformity with the requirements of the Securities
Act, and such other documents (including, without limitation, prospectus amendments and supplements as are prepared by the Company
in accordance with Section 4(a) above) as the selling Holders may reasonably request in order to facilitate the disposition
of such selling Holders’ Registrable Securities;

 

(c)   Use best efforts
to comply with all applicable rules and regulations of the SEC under the Securities Act and the Exchange Act, including, without
limitation, Rule 172 under the Securities Act, file any final prospectus, including any supplement or amendment thereof, with the
SEC pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing if, at any time during the Effectiveness
Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof, the Holders are required to
deliver a prospectus in connection with any disposition of Registrable Securities; notify the selling Holders of the happening
of any event as a result of which the prospectus included in or relating to a Registration Statement contains an untrue statement
of a material fact or omits any fact necessary to make the statements therein not misleading; and, thereafter, subject to Section
9 hereof, the Company will promptly prepare (and, when completed, give notice and provide a copy thereof to each selling Holder)
a supplement or amendment to such prospectus so that such prospectus will not contain an untrue statement of a material fact or
omit to state any fact necessary to make the statements therein not misleading; provided, however, that upon such
notification by the Company (which shall be a Suspension pursuant to Section 9), the selling Holders will not offer or sell
Registrable Securities until the Company has notified the selling Holders that it has prepared a supplement or amendment to such
prospectus and filed it with the SEC or, if the Company does not then meet the conditions for the use of Rule 172, delivered copies
of such supplement or amendment to the selling Holders (it being understood and agreed by the Company that the foregoing proviso
shall in no way diminish or otherwise impair the Company’s obligation to promptly prepare a prospectus amendment or supplement
as above provided in this Section 4(c) and deliver copies of same as above provided in Section 4(b) hereof); and

 

(d)   Use its best efforts
to register and qualify the Registrable Securities covered by a Registration Statement under such other securities or Blue Sky
laws of such states as shall be reasonably appropriate in the opinion of the Company, provided, however, that the
Company shall not be required in connection therewith or as a condition thereto to qualify to do business.

 

    	6

    	 

    
 

(e)   Subject to the terms
and conditions of this Agreement, including Section 2 hereof, the Company shall use its best efforts to (i) prevent the
issuance of any stop order or other suspension of effectiveness of any Registration Statement, or the suspension of the qualification
of any of the Registrable Securities for sale in any jurisdiction in the United States, and (ii) if such an order or suspension
is issued, obtain the withdrawal of such order or suspension at the earliest practicable moment and notify each Holder of Registrable
Securities of the issuance of such order and the resolution thereof or its receipt of notice of the initiation or threat of any
proceeding for that purpose.

 

(f)   The Company shall
comply with all requirements of FINRA, if any, with regard to the issuance of the Registrable Securities and the quotation thereof
on the OTC Bulletin Board and such other securities exchange or automated quotation system, as applicable. 

 

(g)   The Company will
file any Registration Statement and all amendments and supplements thereto electronically on EDGAR.

 

5.   OBLIGATIONS
OF THE PLACEMENT AGENT AND THE HOLDERS.

 

(a)   Each Holder
agrees to cooperate with the Company as reasonably requested by the Company in connection with the filing of any Registration Statement
hereunder, unless such Holder has notified the Company in writing that such Holder elects to exclude all of its Registrable Securities
from such Registration Statement.

 

(b)   Each Holder
agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 4(c),
each Holder shall immediately discontinue disposition of Registrable Securities pursuant to any Registration Statement covering
such Registrable Securities until such Holders receipt of the copies of the supplemented or amended prospectus contemplated by
Section 4(c) or receipt of notice that no supplement or amendment is required.

 

(c)   Each Holder
who is a member or affiliated or associated with member(s) of FINRA will agree, if requested by FINRA, to sign a lock-up, the form
of which shall be satisfactory to FINRA (the “FINRA Lock-Up”), in connection with the transactions contemplated
by the Subscription Agreement.

 

6.   EXPENSES
OF REGISTRATION.

 

(a)   All expenses incurred
in connection with the registration of the Registrable Securities pursuant to this Agreement (excluding underwriting, brokerage
and other selling commissions and discounts), including without limitation all registration and qualification and filing fees,
printing, fees and disbursements of counsel for the Company and fees and expenses shall be borne by the Company; provided,
however, other than as provided in this Section 6(a), the Holders shall be required to pay the expenses of
counsel and any other advisors for the Holders and any brokerage or other selling discounts or commissions and any other expenses
incurred by the Holders for their own account.

 

    	7

    	 

    
 

(b)   Until such time as all of the Registrable Securities have been sold pursuant to an effective
Registration Statement, the Company shall take such reasonable action as the Holder may request (including,
without limitation, promptly obtaining any required legal opinions from Company counsel necessary to effect the sale of the Registrable
Securities under Rule 144 and paying the related fees and expenses of such counsel), to the extent required from time to time to
enable such Holder to sell the Registrable Securities without registration under the Securities Act pursuant to the provisions
of Rule 144 under the Securities Act (or any successor provision). The Company further covenants to take such action and to
provide such legal opinions within five (5) Business Days after receipt from such Holder (or its representative) of documentation
reasonably required by the Company’s counsel to provide such opinion.

 

7.   INDEMNIFICATION.

 

(a)   To the extent
permitted by law, the Company will indemnify and hold harmless each selling Holder, and each officer and director of such selling
Holder and each person, if any, who controls such selling Holder, within the meaning of the Securities Act, against any losses,
claims, damages or liabilities, joint or several, to which they may become subject under the Securities Act or otherwise, insofar
as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon (i) any untrue or
alleged untrue statement of any material fact contained in any Registration Statement, in any preliminary prospectus or final prospectus
relating thereto or in any amendments or supplements to any Registration Statement or any such preliminary prospectus or final
prospectus, or the omission or alleged omission to state therein a material fact required to be stated therein, or necessary to
make the statements therein not misleading; (ii) any blue sky application or other document executed by the Company specifically
for that purpose or based upon written information furnished by the Company filed in any state or other jurisdiction in order to
qualify any or all of the Registrable Securities under the securities laws thereof (any such application, document or information
herein called a “Blue Sky Application”); (iii) the omission or alleged omission to state in a Blue Sky
Application a material fact required to be stated therein or necessary to make the statements therein not misleading; (iv) any
violation by the Company or its agents of any rule or regulation promulgated under the Securities Act applicable to the Company
or its agents and relating to action or inaction required of the Company in connection with such registration of the Registrable
Securities; or (v) any failure to register or qualify the Registrable Securities included in any such Registration Statement in
any state where the Company or its agents has affirmatively undertaken or agreed in writing that the Company will undertake such
registration or qualification on a Holder’s behalf; and will reimburse such selling Holder, or such officer, director or
controlling person of such selling Holder for any legal or other expenses reasonably incurred by them in connection with investigating
or defending any such loss, claim, damage, liability or action; provided, however, that the indemnity agreement contained
in this Section 7(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action
if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall
the Company be liable in any such case for any such loss, damage, liability or action to the extent that it arises out of or is
based upon (i) an untrue statement or alleged untrue statement or omission made in connection with any Registration Statement,
any preliminary prospectus or final prospectus relating thereto or any amendments or supplements to any Registration Statement
or any such preliminary prospectus or final prospectus, in reliance upon and in conformity with written information furnished expressly
for use in connection with any Registration Statement or any such preliminary prospectus or final prospectus by the selling Holders
or (ii) at any time when the Company has advised the Holder in writing that the Company does not meet the conditions for use of
Rule 172 and as a result that the Holder is required to deliver a current prospectus in connection with any disposition of Registrable
Securities, an untrue statement or alleged untrue statement or omission in a prospectus that is (whether preliminary or final)
corrected in any subsequent amendment or supplement to such prospectus was delivered to the selling Holder before the pertinent
sale or sales by the selling Holder.

 

    	8

    	 

    
 

(b)   To the extent permitted
by law, each selling Holder will severally and not jointly indemnify and hold harmless the Company, each of its directors, each
of its officers who have signed any Registration Statement, each person, if any, who controls the Company within the meaning of
the Securities Act, against any losses, claims, damages or liabilities to which the Company or any such director, officer, controlling
person, may become subject to, under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or
actions in respect thereto) arise out of or are based upon any untrue or alleged untrue statement of any material fact contained
in any Registration Statement or any preliminary prospectus or final prospectus, relating thereto or in any amendments or supplements
to any Registration Statement or any such preliminary prospectus or final prospectus, or arise out of or are based upon the omission
or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein
not misleading, in each case to the extent and only to the extent that such untrue statement or alleged untrue statement or omission
or alleged omission (i) was made in any Registration Statement, in any preliminary prospectus or final prospectus relating thereto
or in any amendments or supplements to any Registration Statement or any such preliminary prospectus or final prospectus, in reliance
upon and in conformity with written information furnished by the selling Holder expressly for use in connection with any Registration
Statement, or any preliminary prospectus or final prospectus or (ii) at any time when the Company has advised the Holder in writing
that the Company does not meet the conditions for use of Rule 172 and as a result that the Holder is required to deliver a current
prospectus in connection with any disposition of Registrable Securities, an untrue statement or alleged untrue statement or omission
in a prospectus that is (whether preliminary or final) corrected in any subsequent amendment or supplement to such prospectus was
corrected in any subsequent amendment or supplement to such prospectus that was delivered to the selling Holder before the pertinent
sale or sales by the selling Holder; and such selling Holder will reimburse any legal or other expenses reasonably incurred by
the Company or any such director, officer, controlling person; provided, however, that the liability of each selling
Holder hereunder shall be limited to the net proceeds received by such selling Holder from the sale of Registrable Securities giving
rise to such liability, and provided further, that the indemnity agreement contained in this Section 7(b)
shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected
without the consent of those selling Holder(s) against which the request for indemnity is being made (which consent shall not be
unreasonably withheld).

 

    	9

    	 

    

 

(c)   Promptly after receipt
by an indemnified party under this Section 7 of notice of the commencement of any action, such indemnified party will, if
a claim in respect thereof is to be made against any indemnifying party under this Section 7, notify the indemnifying party
in writing of the commencement thereof and the indemnifying party shall have the right to participate in and, to the extent the
indemnifying party desires, jointly with any other indemnifying party similarly noticed, to assume at its expense the defense thereof
with counsel satisfactory to the indemnifying party or indemnifying parties, but the omission so to notify the indemnifying party
will not relieve it from any liability which it may have to any indemnified party for contribution or otherwise under the indemnity
agreement contained in this Section 7 (except to the extent that such omission materially and adversely affects the indemnifying
party’s ability to defend such action). In the event that the indemnifying party assumes any such defense, the indemnified
party may participate in such defense with its own counsel and at its own expense, provided, however, if the defendants
in any such action include both the indemnified party and the indemnifying party and the indemnified party shall have reasonably
concluded, based on an opinion of counsel reasonably satisfactory to the indemnifying party, that there may be a conflict of interest
between the positions of the indemnifying party and the indemnified party in conducting the defense of any such action or that
there may be legal defenses available to it and/or other indemnified parties which are different from or additional to those available
to the indemnifying party, the indemnified party or parties shall have the right to select separate counsel to assume such legal
defenses and to otherwise participate in the defense of such action on behalf of such indemnified party or parties. Upon receipt
of notice from the indemnifying party to such indemnified party of its election to assume the defense of such action and approval
by the indemnified party of counsel, the indemnifying party will not be liable to such indemnified party under this Section
7 for any legal or other expenses subsequently incurred by such indemnified party in connection with the defense thereof unless
the indemnified party shall have employed such counsel in connection with the assumption of legal defenses in accordance with the
proviso to the preceding sentence (it being understood, however, that the indemnifying party shall not be liable for the expenses
of more than one separate counsel and one local counsel, reasonably satisfactory to such indemnifying party, representing all of
the indemnified parties who are parties to such action in which case the reasonable fees and expenses of counsel shall be at the
expense of the indemnifying party.

 

(d)   Notwithstanding anything
to the contrary herein, the indemnifying party shall not be entitled to settle any claim, suit or proceeding unless in connection
with such settlement the indemnified party receives an unconditional release with respect to the subject matter of such claim,
suit or proceeding and such settlement does not contain any admission of fault by the indemnified party.

 

(e)   If the indemnification
provided for in this Section 7 is unavailable to or insufficient to hold harmless an indemnified party under subsection
(a) or (b) above in respect of any losses, claims, damages or liabilities (or actions or proceedings in respect thereof) referred
to therein, then each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of
such losses, claims, damages or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect the
relative fault of the Company on the one hand and the Holders on the other in connection with the statements or omissions or other
matters which resulted in such losses, claims, damages or liabilities (or actions in respect thereof), as well as any other relevant
equitable considerations. The relative fault shall be determined by reference to, among other things, in the case of an untrue
statement, whether the

 

    	10

    	 

    
 

untrue statement relates to information supplied by the Company on the one hand or a Holder on the other
and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such untrue statement.
The Company and the Holders agree that it would not be just and equitable if contribution pursuant to this subsection (e) were
determined by pro rata allocation (even if the Holders were treated as one entity for such purpose) or by any other method of allocation
which does not take into account the equitable considerations referred to above in this subsection (e). The amount paid or payable
by an indemnified party as a result of the losses, claims, damages or liabilities (or actions in respect thereof) referred to above
in this subsection (e) shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in
connection with investigating or defending any such action or claim. No person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. The Holders’ obligations in this subsection to contribute are several in proportion to their sales of
Registrable Securities to which such loss relates and not joint. In no event shall the contribution obligation of a Holder be greater
in amount than the dollar amount of the net proceeds (net of all expenses paid by such Holder in connection with any claim relating
to this Section 7 and the amount of any damages such Holder has otherwise been required to pay by reason of such untrue
or alleged untrue statement or omission or alleged omission) received by it upon the sale of the Registrable Securities giving
rise to such contribution obligation.

 

8.   REPORTS UNDER
THE EXCHANGE ACT. With a view to making available to the Holders the benefits of Rule 144 and any other rule or regulation
of the SEC that may at any time permit the Holders to sell the Registrable Securities to the public without registration, the Company
agrees: (i) to make and keep public information available as those terms are understood in Rule 144, (ii) to file with the SEC
in a timely manner all reports and other documents required to be filed by an issuer of securities registered under the Securities
Act or the Exchange Act pursuant to Rule 144, (iii) as long as any Holder owns any Registrable Securities, to furnish in writing
upon such Holder’s written request a written statement by the Company that it has complied with the reporting requirements
of Rule 144 and of the Securities Act and the Exchange Act, and to furnish upon written request to such Holder a copy of the most
recent annual or quarterly report of the Company, and such other reports and documents so filed by the Company as may be reasonably
requested in availing such Holder of any rule or regulation of the SEC permitting the selling of any such Registrable Securities
without registration and (iv) undertake any additional actions reasonably necessary to maintain the availability of the use of
Rule 144.

 

9.   SUSPENSION.
Notwithstanding anything in this Agreement to the contrary, in the event (i) of any non-voluntary demand on the Company by the
SEC or any other federal or state governmental authority during the period of effectiveness of any Registration Statement for amendments
or supplements to any Registration Statement or related prospectus or for additional information; (ii) of the issuance by the SEC
or any other federal or state governmental authority of any stop order suspending the effectiveness of any Registration Statement
or the initiation of any proceedings for that purpose; (iii) of the receipt by the Company of any notification with respect to
the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction
or the initiation of any proceeding for such

 

    	11

    	 

    
 

purpose; or (iv) of any event or circumstance which requires in order to comply with
applicable law the making of any changes in any Registration Statement or related prospectus, or any document incorporated or deemed
to be incorporated therein by reference, so that, in the case of any Registration Statement, it will not contain any untrue statement
of a material fact or any omission to state a material fact required to be stated therein or necessary to make the statements therein
not misleading, and that in the case of the prospectus, it will not contain any untrue statement of a material fact or any omission
to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading, then the Company shall furnish to the selling Holders a certificate signed by the President
or Chief Executive Officer of the Company setting forth in detail the facts relating to one or more of the above described circumstances,
and the right of the selling Holders to use any Registration Statement (and the prospectus relating thereto) shall be suspended
for a period (the “Suspension Period”) of not more than ten (10) days after delivery by the Company of
the certificate referred to above in this Section 9. During the Suspension Period, none of the Holders shall offer or sell
any Registrable Securities pursuant to or in reliance upon any Registration Statement (or the prospectus relating thereto). The
Company shall use its best efforts to terminate any Suspension Period as promptly as practicable.

 

10.   TRANSFER OF REGISTRATION
RIGHTS. A Holder shall have the right and may transfer or assign, at any time and from time to time, in whole or in part, to
one or more Persons its rights hereunder in connection with the transfer of the Registrable Securities by such Holder to such person,
provided that (a) such Holder complies with all laws applicable thereto, (b) the Company is furnished with written notice of the
name and address of such transferee or assignee and the Registrable Securities to which such registration rights are being transferred,
(c) at or before the time the Company received the written notice contemplated by clause (b) of this sentence the transferee or
assignee agrees in writing (i) that such transferee or assignee is an “accredited purchaser” as that term is defined
in Rule 501 of Regulation D, (ii) to be bound by all of the terms and conditions of this Agreement by duly executing and delivering
to the Company an Instrument of Adherence in the form attached as Annex B hereto.

 

11.   ENTIRE AGREEMENT.
This Agreement and the Subscription Agreement constitute and contain the entire agreement and understanding of the parties with
respect to the subject matter hereof, and supersede any and all prior negotiations, correspondence, agreements or understandings
with respect to the subject matter hereof.

 

12.   MISCELLANEOUS.

 

(a)   This Agreement may
not be amended, modified or terminated, and no rights or provisions may be waived, except with the written consent of the Company
and the holders of a majority of the Registrable Securities issued and outstanding; provided, that, no consent shall
be required in order to add additional Purchasers as parties hereto in accordance with the Offering.

  

    	12

    	 

    
 

(b)   This Agreement shall
be governed by and construed in accordance with the internal laws of the State of New York without regard to the conflicts of laws
principles thereof. The parties hereto expressly and irrevocably agree that any suit or proceeding arising directly and/or indirectly
pursuant to or under this Agreement shall be brought solely in a federal or state court located in the City, County and State of
New York. By its execution hereof, the parties hereby covenant and irrevocably submit to the in personam jurisdiction of the federal
and state courts located in the City, County and State of New York and agree that any process in any such action may be served
upon any of them personally, or by certified mail or registered mail upon them or their agent, return receipt requested, with the
same full force and effect as if personally served upon them in New York City. The parties hereto waive any claim that any such
jurisdiction is not a convenient forum for any such suit or proceeding and any defense or lack of in personam jurisdiction with
respect thereto. In the event of any such action or proceeding, the party prevailing therein shall be entitled to payment from
the other party hereto of its reasonable counsel fees and disbursements in an amount judicially determined.

 

(c)   Any notices, reports
or other correspondence (hereinafter collectively referred to as “correspondence”) required or permitted to be given
hereunder shall be in writing and shall be sent by postage prepaid first class mail, courier or telecopy or delivered by hand to
the party to whom such correspondence is required or permitted to be given hereunder, and shall be deemed sufficient upon receipt
when delivered personally or by courier, overnight delivery service or confirmed facsimile, or three (3) business days after being
deposited in the regular mail as certified or registered mail (airmail if sent internationally) with postage prepaid, if such notice
is addressed to the party to be notified at such party’s address or facsimile number as set forth below:

 

(i)   All correspondence to the Company shall be addressed
as follows:

 

SimplePons, Inc.

220 Congress Park Drive

Delray Beach, FL 33445

Attention:Mr. Brian S.
John, President

Facsimile:(561) 330-9699

 

with a copy to:

 

Schneider Weinberger LLP

2200 Corporate Boulevard, Suite
210

Boca Raton, FL 33431

Attention:James M. Schneider, Esq.

Facsimile:(561) 362-9612

 

(ii)   All correspondence
to any Purchaser shall be sent to such Purchaser at the address set forth in the signature page to the Subscription Agreement.

 

(iii)   Any party may change
the address to which correspondence to it is to be addressed by written notification as provided for herein.

 

    	13

    	 

    

 

(d)   The parties acknowledge
and agree that in the event of any breach of this Agreement, remedies at law may be inadequate, and each of the parties hereto
shall be entitled to seek specific performance of the obligations of the other parties hereto and such appropriate injunctive relief
as may be granted by a court of competent jurisdiction.

 

(e)   Should any part or
provision of this Agreement be held unenforceable, the unenforceable part or provisions shall be replaced with a provision which
accomplishes, to the extent possible, the original business purpose of such part or provision in a valid and enforceable manner,
and the remainder of this Agreement shall remain binding upon the parties hereto.

 

(f)   This Agreement
may be executed in a number of counterparts, any of which together shall for all purposes constitute one Agreement, binding on
all the parties hereto notwithstanding that all such parties have not signed the same counterpart.

 

IN WITNESS WHEREOF,
the parties hereto have executed this Registration Rights Agreement as of the date and year first above written.

 

	 	SIMPLEPONS, INC.
	 	 	 
	 	By:	 
	 	 	Brian S. John, 
	 	 	Chief Executive Officer 

  

THE PURCHASER’S SIGNATURE TO THE
SUBSCRIPTION AGREEMENT SHALL CONSTITUTE THE PURCHASER’S SIGNATURE TO THIS REGISTRATION RIGHTS AGREEMENT.

 

14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}]]